Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_provenance.
- befree-20150227 importedOn "2015-02-27" NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_provenance.
- NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_assertion wasGeneratedBy ECO_0000203 NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_provenance.
- NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_assertion wasDerivedFrom befree-20150227 NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_provenance.
- NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_assertion SIO_000772 2464605 NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_provenance.
- NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_assertion evidence source_evidence_literature NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_provenance.
- NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_assertion description "[Multidrug-resistant human neuroblastoma cell lines obtained by selection with vincristine or actinomycin D from two independent clonal lines, SH-SY5Y and MC-IXC, have 3- to 30-fold more cell surface epidermal growth factor (EGF) receptors than the drug-sensitive parental cells as indicated by EGF binding assays and immunoprecipitation, affinity-labeling, and phosphorylation studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367946.RADwsPeRXJ2Yf5fyjf4Q3fv4RLPxpeUUmEq48KCKgt7Oo130_provenance.